Strata Critical Medical, Inc. (SRTA) Stock Total Returns
Growth of $10,000 chart
2021-04-16 to 2026-04-16 to
$
%
%
Loading chart…
Investment Performance
Final Value
$4,514
Total Return
-54.86%
CAGR
-14.71%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +0.50% |
| Median | -1.47% |
| Best | +64.98% |
| Worst | -38.95% |
| % of Windows Positive | 46.8% |
1-Year (252 Trading Days)
| Average | -8.24% |
| Median | -13.97% |
| Best | +84.01% |
| Worst | -71.87% |
| % of Windows Positive | 38.3% |
3-Year (756 Trading Days)
| Average | -31.54% |
| Median | -46.11% |
| Best | +77.36% |
| Worst | -74.63% |
| % of Windows Positive | 23.0% |
Risk Metrics
| Maximum Drawdown | -82.12% |
| Average Drawdown | -57.04% |
| Drawdown Duration | 1142 Trading Days (Unrecovered) |
| Sortino Ratio | 0.17 |
| Calmar Ratio | -0.18 |
| CVaR (5%) | -8.44% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -6.44% (-20.51% ann.) | $644.49 | $0.00 | $0.00 | $0.00 |
| 2025 | +13.18% | +$1317.65 | $0.00 | $0.00 | $0.00 |
| 2024 | +20.40% | +$2039.66 | $0.00 | $0.00 | $0.00 |
| 2023 | -1.40% | $139.66 | $0.00 | $0.00 | $0.00 |
| 2022 | -59.46% | $5945.65 | $0.00 | $0.00 | $0.00 |
| 2021 | -20.31% | $2030.68 | $0.00 | $0.00 | $0.00 |
| 2020 | +12.72% | +$1271.62 | $0.00 | $0.00 | $0.00 |
| 2019 partial | +0.82% (+5.47% ann.) | +$82.05 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | November 5, 2019 – February 19, 2020 | +2.56% | +9.12% | +$256.41 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -3.00% | -29.37% | $300.00 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -0.30% | -0.48% | $30.06 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -13.29% | -12.66% | $1329.31 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -48.12% | -50.18% | $4812.29 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -29.50% | -17.19% | $2950.12 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 16, 2026 | +41.51% | +24.68% | +$4150.92 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.